PLETHICO - Plethico Pharmaceuticals

Plethico Pharmaceuticals

PLETHICO · Pharma > Pharmaceuticals & Drugs · Chairman: Shashikant Patel · MD: Shashikant Patel · Listing date: May 5, 2006

Stock Price vs Company Growth

0.0%

10y

13.8%

all

18.7%

🤔 How to analyze this graph?

Last Traded Price

₹ 9.05 0%

N/A

9.05

Company Overview

Sales

765 Cr

Growth: -31.8%

Profit after Tax

-278 Cr

Growth: -1055.5%

Micro Cap

30.8 Cr

P/S: 0.0x

Industry P/S: 3.2x

Fundamentals

Sales (Cr)	₹ 765
Growth	-31.8%
EBITDA	14.8%
P/S	0.0x
Dividend	0.0%
P/E	-0.1x
Book Value	₹ 415
PEG Ratio	0.0x
ROE	-17.8%
P/B	0.0x

Shareholding Pattern

Institutions

Punjab National Bank

9.04 %

State Bank Of India, Industrial Finance Branch, Indore

2.94 %

Hypons Fund Limited

2.64 %

United India Insurance Company Limited

1.9 %

General Insurance Corporation Of India

1.47 %

Promoters

Shashikant Patel

55.45 %

Chirag Patel

2.3 %

Others

Increase Decrease No change

Company Profile Detailed

Plethico Pharmaceuticals, established in 1991, is a leading global healthcare / pharmaceutical company with a strong emphasis on herbal and neutraceutical segments. The company focused on manufacturing and marketing a range of branded generic pharmaceutical formulations, has rapidly evolved and now engages in the manufacture, marketing and distribution of pharmaceutical and allied healthcare products in the neutraceutical and herbal segments in India and internationally.